Class 4 Recall on Zoledronic acid 5mg solution for infusion

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from the above batch contain a Patient Information Leaflet (PIL) for Temozolomide 180mg Capsules..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch

1186964Zoledronic acid 5mg solution for infusionRanbaxy (UK) LtdJKT1576A

For any enquiries, please contact Ranbaxy / Sun Pharmaceuticals customer services team: Tel: 020 8848 5050; email: cserv.uk@sunpharma.com.
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.